Literature DB >> 27100477

Traumatic brain injury: a review of characteristics, molecular basis and management.

Ke Wang, Daming Cui, Liang Gao1.   

Abstract

Traumatic brain injury (TBI) is a critical cause of hospitalization, disability, and death worldwide. The global increase in the incidence of TBI poses a significant socioeconomic burden. Guidelines for the management of acute TBI mostly pertain to emergency treatment. Comprehensive gene expression analysis is currently available for several animal models of TBI, along with enhanced understanding of the molecular mechanisms activated during injury and subsequent recovery. The current review focuses on the characteristics, molecular basis and management of TBI.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27100477     DOI: 10.2741/4426

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  4 in total

1.  Treatment effects of monosialotetrahexosylganglioside on severe traumatic brain injury in adults.

Authors:  Hanqing Chu; Jindan Gao
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

Review 2.  The Neurobiological Links between Stress and Traumatic Brain Injury: A Review of Research to Date.

Authors:  Lexin Zheng; Qiuyu Pang; Heng Xu; Hanmu Guo; Rong Liu; Tao Wang
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208

3.  Human umbilical cord mesenchymal stem cell-derived exosomes promote neurological function recovery in rat after traumatic brain injury by inhibiting the activation of microglia and astrocyte.

Authors:  Lianxu Cui; Wei Luo; Wenkang Jiang; Haomin Li; Junrong Xu; Xiaocui Liu; Bingyun Wang; Jinhui Wang; Guoqiang Chen
Journal:  Regen Ther       Date:  2022-08-28       Impact factor: 3.651

Review 4.  Traumatic Brain Injury and Blood-Brain Barrier (BBB): Underlying Pathophysiological Mechanisms and the Influence of Cigarette Smoking as a Premorbid Condition.

Authors:  Farzane Sivandzade; Faleh Alqahtani; Luca Cucullo
Journal:  Int J Mol Sci       Date:  2020-04-14       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.